Lymphoma / Leukemia News From Medical News TodayLatest Lymphoma / Leukemia News From Medical News Today.Genmab And GlaxoSmithKline Announce Positive Top-Line Results In Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study- August 1, 2008 Genmab AS (OMX: GEN) and GlaxoSmithKline (LSE and NYSE: GSK) announced positive top-line results from an interim analysis of the Phase III pivotal study evaluating ofatumumab (HuMax-CD20(R)) to treat two groups of chronic lymphocytic leukemia (CLL) patients with high unmet medical need. At the interim analysis, the study met the primary endpoint in both populations and the results from the secondary endpoints also support the primary endpoint.http://www.medicalnewstoday.com/articles/116862.php Aegera Initiates A Fifth Phase 1 And 2 Clinical Trial For AEG35156- August 1, 2008 Aegera Therapeutics Inc. is pleased to announce the dosing of the first patient in a fifth phase 1 and 2 clinical oncology study of AEG35156, a second generation antisense therapeutic targeting XIAP, a key member of the Inhibitor of Apoptosis protein family.http://www.medicalnewstoday.com/articles/116863.php Lab Study Shows Methadone Breaks Resistance In Untreatable Forms Of Leukemia- August 1, 2008 Researchers in Germany have discovered that methadone, an agent used to break addiction to opioid drugs, has surprising killing power against leukemia cells, including treatment resistant forms of the cancer. Their laboratory study, published in the August 1 issue of Cancer Research, a journal of thehttp://www.medicalnewstoday.com/articles/116688.php |